Acella Pharmaceuticals Appoints New CEO

Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announced the appointment of  Harold. A Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his role as Chief Operating Officer, has been instrumental in helping Acella build a successful portfolio of generic and specialty, niche pharmaceutical drug and medical device products. Mr. Deas will be driving corporate expansion while identifying strategic opportunities within the markets core to the company's business. 

"Acella is an important niche company," said Mr. Deas.  "It fills an essential role in the marketplace. I am pleased to be a part of Acella's continued success, and to meeting the changing needs of our customers and industry."